Skip to main content
Clinical Trials/NCT00958113
NCT00958113
Completed
Not Applicable

Autoimmune Thyroid Disease Genetic Study

University of Colorado, Denver1 site in 1 country199 target enrollmentJuly 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hashimoto's Disease
Sponsor
University of Colorado, Denver
Enrollment
199
Locations
1
Primary Endpoint
Map and identify genes that confer susceptibility to Autoimmune Thyroid Disease (AITD)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The hypothesis of this project is that specific genes can be identified that contribute to genetic susceptibility to autoimmune thyroid disease (AITD) in different populations. The specific aim of this project is carry out one or more genomewide association studies (GWAS) to map and ultimately identify genes that confer susceptibility to AITD. AITD consists principally of Hashimoto's Thyroiditis (HT) and Graves' Disease (GD), characterized clinically generally by hypothyroidism and hyperthyroidism, respectively. Both HT and GD are autoimmune diseases characterized by infiltration of the thyroid by T and B cells that are reactive with thyroid antigens and by the production of thyroid autoantibodies (TAB). While there is some evidence that there may be genes specific to either GD or HT, other genes appear to be common to both, and some genes may furthermore be in common to susceptibility to other autoimmune diseases. Genes known to play a role in AITD include HLA, CTLA4, thyroglobulin (TG), THSR, and CD40, PTPN2, and PTPN22, several of which are also involved in susceptibility to other autoimmune diseases. All of these genes interact in a complex manner that has yet to be understood. Furthermore, it seems clear that relatively few of the genes involved in susceptibility to AITD have thus far been discovered.

Registry
clinicaltrials.gov
Start Date
July 2009
End Date
May 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of abnormal thyroid function (hypo or hyperthyroidism) due to autoimmune thyroid disease

Exclusion Criteria

  • Lack of documentation of abnormal thyroid function or clear evidence of autoimmune etiology

Outcomes

Primary Outcomes

Map and identify genes that confer susceptibility to Autoimmune Thyroid Disease (AITD)

Time Frame: Approximately one year after all samples are collected

SNP genotypes (allele frequencies, genotype frequencies) will be compared in cases versus controls.

Study Sites (1)

Loading locations...

Similar Trials